PepsiCo is running out of time to deliver on the ​growth and margin targets it set out after activist investor Elliott Investment Management took a roughly $4 billion stake a ‌year ago, as the threat of GLP-1 weight-loss drugs to salty snacks and sugary drinks intensifies.